Qureight and Remedy Cell have collaborated to validate the mechanism of action of RC-0315 in the Phase Ib clinical trial for treating idiopathic pulmonary fibrosis (IPF). The trial’s primary objective ...

VC funding into AI tools for healthcare was projected to hit $11 billion last year -- a headline figure that speaks to the ...

Diagnosis of PDB is a combination of clinical evaluation, imaging and histopathological assessment. If an underlying cancer ...

Study presented at ESGO 2025 highlights the accuracy of preoperative tumour size assessment in stage IB2 cervical cancer and ...

Fatty pancreas disease, characterized by intra-pancreatic fat deposition, is more prevalent than diabetes, pancreatitis, and ...

MRI findings uncover an unexpected mismatch between Alzheimer’s pathology and cognitive function in a unique case study.

Poor retinal health in midlife is associated with increased risk for Alzheimer’s disease and related dementias later on, ...

Traditional technologies such as X-ray, ultrasound or MRI don't have the resolution to see disease at the cellular level. As a result, surgeons must wait up to 10 days for pathology results to either ...

The digital pathology module is an addition to the health system's use of Sectra's enterprise imaging solution within radiology, mammography, and orthopaedics since 2018. This module will enable their ...

Elevated levels of p-tau 181 and 217 in cerebrospinal fluid are considered to reflect early Alzheimer's disease pathology.

Designed to streamline lab efficiencies, Epredia’s E1000 Dx scanner can image up to 1,500 tissue samples daily.